Blake Aftab

Company: Adicet Bio Inc.

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Understanding the Merits & Feasibilities of HLA Matching 11:30 am

Explore the importance of HLA matching in improving patient outcomes and reducing the risk of allogeneic rejection in allogeneic therapies Evaluate the feasibility and logistical considerations of implementing HLA matching in clinical settings to optimize donor-recipient compatibility Discuss recent advancements and tools that facilitate HLA matching processes, enhancing the overall efficacy of allogeneic treatmentsRead more

day: Day Two - Track A AM

Developing Allo-CAR-Ts Against Solid Tumors & Autoimmune Indications 3:30 pm

Discussing current clinical programs in solid tumors and several autoimmune conditions Leveraging armoring technologies to breach into solid tumorsRead more

day: Conference Day One